- Dosage: 5% Glucose
- Volume: 500ml per bottle / bag
- Packaging: 500ml per bottle / bag *30/carton
- Shelf Life: 36 months
Package:
Product Description
Product Overview
Heparin Sodium Injection 5000IU/2mL is a sterile, aqueous solution of heparin sodium intended for parenteral administration. Each 2mL ampoule contains 5000 international units (IU) of heparin sodium at a concentration of 2500IU/mL. Heparin sodium is a highly sulfated glycosaminoglycan mixture of varying molecular weights (ranging from approximately 3,000 to 30,000 Daltons, with a mean molecular weight of approximately 12,000 to 15,000 Daltons), derived from porcine intestinal mucosa. It is a widely used parenteral anticoagulant that exerts its effect by potentiating the activity of antithrombin III, a naturally occurring plasma protease inhibitor, and is used in the management and prevention of thromboembolic disorders, as well as for anticoagulation during extracorporeal procedures such as hemodialysis and cardiopulmonary bypass.
5% Dextrose Injection 500ml: What the Published Guidance Says
Crystalloid infusion solutions, energy substrates and parenteral nutrition components — the fluid-resuscitation and supportive-care layer underneath almost every inpatient protocol.
Before 5% Dextrose Injection 500ml is quoted, we confirm the monograph, the strength on the artwork and the release testing required by your market — the points summarised here.
- Presentation is part of the specification WHO's criterion for an essential medicine includes that it be available in appropriate dosage forms for the intended uses and patients. For infusion solutions that criterion is expressed as fill volume and container format — the difference between a 500 mL bottle and a 1 L bag is a formulary decision before it becomes a price decision. WHO — Essential medicines (fact sheet)
- Electrolyte composition is what separates saline from balanced solutions The Model List publishes the electrolyte content of each crystalloid it carries: sodium chloride 0.9% at Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L, the 5% + 0.9% glucose/sodium chloride combination at 150 mmol/L, and the 5% + 0.45% combination at 75 mmol/L. Comparing those figures against plasma composition is how a formulary committee decides which fluid to standardise on — and why lactated Ringer's, with a more physiological profile, is frequently the resuscitation default. WHO eEML — Glucose + sodium chloride
- The Model List specifies the crystalloid formulations The 24th WHO Model List (2025) carries sodium chloride 0.9% isotonic (equivalent to Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L) and glucose + sodium chloride combinations of 4% + 0.18%, 5% + 0.9% and 5% + 0.45%, classified under solutions correcting water, electrolyte and acid-base disturbances. Glucose + sodium chloride was first added in 1979. WHO eEML — Glucose + sodium chloride
Each point above is reproduced because it has a practical consequence for 5% Dextrose Injection 500ml: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.
5% Dextrose Injection 500ml — Supply Parameters
| Product Name | Heparin Sodium Injection |
| Specification | 5000IU/2mL (2500IU/mL) |
| Dosage Form | Sterile Solution for Injection / Infusion |
| Active Ingredient | Heparin Sodium (porcine mucosal origin) |
| Pharmacological Class | Anticoagulant / Glycosaminoglycan / Indirect Thrombin Inhibitor |
| Route of Administration | Intravenous injection (bolus), intravenous infusion (after dilution), or deep subcutaneous injection. NOT for intramuscular injection (risk of hematoma). |
| Storage | Store below 25°C, protected from light. Do not freeze. Keep container in outer carton until use. |
| Therapeutic group | IV Fluids — IV Fluids |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Human Albumin 20% 50ml, 20% Fat Emulsion Injection 100ml, Lactated Ringer’s Injection 500mL, 10% Dextrose Injection 500ml, Fructose Injection 5g/250mL.
Quality Control, Pharmacopoeial Standards & Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Release testing for 5% Dextrose Injection 500ml follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
A typical release panel for this presentation covers:
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packaging, Labelling & Export
- Pack size: 2mL amber glass ampoule (or vial, depending on configuration). Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, protected from light. Do not freeze. Keep container in outer carton until use..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Registration, Dossier & Tender Support
The legal manufacturer named on every document for 5% Dextrose Injection 500ml is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
5% Dextrose Injection 500ml is presented here against infusion solutions and parenteral nutrition named in the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.
Frequently Asked Questions
What pack size is available for 5% Dextrose Injection 500ml?
Standard commercial packaging for this line is 2mL amber glass ampoule (or vial, depending on configuration). Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.
What documentation comes with a shipment of 5% Dextrose Injection 500ml?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.
Does the batch documentation for 5% Dextrose Injection 500ml support a registration filing?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which infusion solutions are on the WHO Model List?
Sodium chloride 0.9% isotonic, and glucose + sodium chloride in 4% + 0.18%, 5% + 0.9% and 5% + 0.45% combinations, under solutions correcting water, electrolyte and acid-base disturbances.
Do you supply lactated Ringer's solution?
Yes — lactated Ringer's injection in 500 mL and other fill volumes. Balanced crystalloids have an electrolyte profile closer to plasma than 0.9% saline.
Related IV Fluids Products
- Human Albumin 20% 50ml — 100g
- 20% Fat Emulsion Injection 100ml — 100mL
- Lactated Ringer’s Injection 500mL — 500mL
- 10% Dextrose Injection 500ml — 10g
- Fructose Injection 5g/250mL — 5g
Browse the full IV Fluids range; all Injectables; the complete product catalogue.
Request a Quotation for 5% Dextrose Injection 500ml
Tell us the monograph, pack size and quantity required for 5% Dextrose Injection 500ml 5000IU, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
